Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of AMOT mRNA | decreases expression | 19933214
|
C014211 |
2,3,7,8-tetrachlorodibenzofuran |
2,3,7,8-tetrachlorodibenzofuran affects the expression of AMOT mRNA | affects expression | 18343893
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of AMOT mRNA | increases expression | 18648102
|
C406082 |
monomethylarsonous acid |
[monomethylarsonous acid affects the acetylation of HIST3H3 protein] which affects the methylation of AMOT promoter | affects acetylation|affects methylation | 18448484
|
C017947 |
sodium arsenite |
[sodium arsenite affects the acetylation of HIST3H3 protein] which affects the methylation of AMOT promoter | affects acetylation|affects methylation | 18448484
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of AMOT mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of AMOT mRNA | affects expression | 18343893
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of AMOT mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of AMOT mRNA | decreases expression | 19933214
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of AMOT mRNA | increases expression | 16604517
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 15322242 14514962 11752688 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.88 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.08 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.28 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.81 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.21 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.40 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.68 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.40 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.76 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.76 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.96 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.93 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.54 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.78 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.78 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.78 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.77 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.88 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.88 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.22 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
12.30 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
12.30 | 19716837 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
12.30 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.93 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.32 | 19486331 9022650 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.54 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.05 | 12621046 15340226 15668235 16354765 8697196 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
6.05 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.01 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.50 | 8800419 17551590 14991402 10589399 9125849 16925845 9664655 9224671 9142499 9211117 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
3.10 | 18759878 8156756 12868966 2524372 11298694 14531868 8970840 11906362 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.75 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
3.89 | 16192314 18289764 6679447 9653073 7440962 9022650 11289319 8291058 6482804 18692083 18648102 9328219 1440618 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.89 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
13.23 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
13.23 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.25 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.15 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.43 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.43 | 9664655 16938888 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.40 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.66 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.66 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.02 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.15 | 17312396 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.30 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.34 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.54 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
2,3,7,8-tetrachlorodibenzofuran |
11.95 | 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.95 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.95 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.79 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 15340226 16120746 12621046 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.12 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.36 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 8697196 15340226 18606429 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.40 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.88 | 16778211 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.25 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.14 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.96 | 12200463 12878042 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.07 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.40 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.76 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.76 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.92 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.17 | 6582329 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.87 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.94 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.11 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.30 | 9834237 17339181 19642359 17294898 17712046 16823087 19035177 16891316 16140955 16788101 17506722 17107899 12679006 16935935 17368321 17649720 15748426 17361223 17217047 19075265 17301526 19225113 19029980 16766008 16331271 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.47 | 9224671 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.33 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.36 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.36 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
4.71 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.71 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
6.20 | 3712494 598648 1399818 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.20 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.32 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.36 | 17306315 16712894 17077188 15276417 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 19555203 11884234 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.86 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.45 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.45 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.73 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.20 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.55 | 3581430 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.46 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.46 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.97 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.47 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
10.47 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
13.00 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
13.00 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
13.00 | 9142499 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.65 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.40 | 3988306 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.10 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.10 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.10 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.53 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.79 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.85 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11399792 11118676 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.26 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.86 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.13 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.55 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.36 | 16116481 16283617 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.43 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
10.02 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
10.02 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
10.02 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.98 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.75 | 1399818 7505956 3712494 6587162 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.75 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.02 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.36 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.94 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
8.94 | 20375083 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.94 | 16712894 16452187 17306315 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
10.18 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
10.18 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.99 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.76 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.34 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.18 | 16287080 |